scispace - formally typeset
Y

Yang Xu

Researcher at Seven Oaks General Hospital

Publications -  6
Citations -  319

Yang Xu is an academic researcher from Seven Oaks General Hospital. The author has contributed to research in topics: Anemia & Dialysis. The author has an hindex of 5, co-authored 5 publications receiving 247 citations.

Papers
More filters
Journal ArticleDOI

Non-invasive endothelial function testing and the risk of adverse outcomes: a systematic review and meta-analysis

TL;DR: A systematic review and meta-analysis was performed to determine whether brachial FMD and peripheral arterial tonometry (PAT) are independent risk factors for future cardiovascular events and mortality as discussed by the authors.
Journal ArticleDOI

The Effect of Erythropoietin-Stimulating Agents on Health-Related Quality of Life in Anemia of Chronic Kidney Disease: A Systematic Review and Meta-analysis

TL;DR: An updated systematic review and meta-analysis on the effect of achieving higher hemoglobin targets with ESAs on HRQOL in patients with CKD and those undergoing dialysis is performed.
Journal ArticleDOI

The Diagnostic Accuracy of Tests for Latent Tuberculosis Infection in Hemodialysis Patients: A Systematic Review and Meta-Analysis

TL;DR: The QFT-G and the T-SPOT.TB tests were more sensitive than the TST for diagnosis of latent tuberculosis infection in patients on hemodialysis while offering a comparable level of specificity.
Journal ArticleDOI

Effect of time on dialysis and renal transplantation on endothelial function: a longitudinal analysis.

TL;DR: Endothelial injury worsens over time on dialysis but improves significantly after renal transplantation, and smoking and heart failure were associated with higher sVCAM-1 levels, whereas transplantation was associated with lower sVCam-1 Levels.
Journal ArticleDOI

The Cost Effectiveness of Erythropoietin-Stimulating Agents for Treating Anemia in Patients on Dialysis: A Systematic Review

TL;DR: There is substantial variability in the estimates of the cost-effectiveness of using ESAs in the dialysis population, and new models incorporating recent meta-analyses for estimates of utility, mortality, and hospitalization changes would allow for a more comprehensive answer to this question.